4 years ago
Cumulus Neuroscience Secures £6 Million to Advance 'Fitbit for the Brain' Technology
Belfast-based Cumulus Neuroscience has raised £6 million in a Series A funding round led by the Dementia Discovery Fund, joined by LifeArc and the UK Future Fund
The company will use the funding to advance its next-generation integrated physiological and digital biomarker platform, which aims to accelerate the development of life-changing CNS therapies by providing clinical trial data and AI-powered insights.
ProblemHealthcare
"Difficulty in measuring disease progression and the effects of drugs in clinical trials for central nervous system (CNS) diseases, leading to disappointing results and delayed development of life-changing therapies."
Solution
"Cumulus Neuroscience's wearable headset and AI-powered software analyze brain activity and provide secure, cloud-based data storage and machine learning architecture to safely analyze composite behavioural, physiological, and functional data, enabling fast and meaningful insights into CNS treatment outcomes."
